Skip to content

Attachment and Post-Traumatic Stress Disorder in Military Personnel: Characterization of the French Military Population, Exploration of Biopsychosocial Factors, and Study of the Impact of Security Priming on Emotional Contagion Capacities

Attachment and Post-traumatic Stress Disorder in Military Personnel: Characterisation of the French Military Population, Exploration of Biopsychosocial Factors and Study of the Impact of Reassuring Primers on Emotional Contagion Skills.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06996275
Acronym
AT-HOME
Enrollment
94
Registered
2025-05-30
Start date
2025-05-28
Completion date
2027-05-26
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional Contagion, Post-traumatic Stress Disorder (PTSD)

Keywords

PTSD, complex PTSD, military veteran, emotional contagion, oxytocin, vasopressine

Brief summary

Post-traumatic stress disorder (PTSD) is a pathology that impairs the quality of life of sufferers. In military personnel, it can lead to military incapacity. This psychopathology is characterized by confrontation with one or more traumatic events in the individual's life history. Symptoms include cognitive and mood disorders, avoidance, hyperactivation (hypervigilance and anger) and intrusions (flashbacks and nightmares). Studies show that the prevalence of PTSD in military personnel fluctuates considerably from one situation to another (pre-deployment/post-deployment, etc.). In these at-risk populations, the often more complex PTSD clinic may also account for the heterogeneity of prevalences observed. Nevertheless, PTSD tends to become chronic in military personnel, making it particularly difficult to return to a "previous" state. In French casualties, beyond the symptoms already mentioned, complaints focus on difficulties in social interaction situations involving others in social life (attachment style to others) and in everyday life (public transport, supermarket shopping, social interactions, presence of crowds...). In the context of post-traumatic stress disorder, the investigators would like to explore the processes of social cognition that enable people to interact in their environment, in relation to biological, psychosocial and physiological variables that may constitute risk or maintenance factors for the pathology.

Interventions

None listed

Sponsors

Direction Centrale du Service de Santé des Armées
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion Criteria Common to Both Groups: * Volunteers who agreed to participate in the study and provided written consent * Affiliated with social security * Proficient in the French language Inclusion Criteria Specific to the "Military Personnel with PTSD" Group: * Military personnel diagnosed with post-traumatic stress disorder related to their duties * Participants in activities offered by the wounded service support units

Exclusion criteria

* Adults subject to a protective measure * Refusal to participate in the study * Unrectified Legionnaires

Design outcomes

Primary

MeasureTime frameDescription
To characterize attachment styles within a military population by comparing a group of military personnel without PTSD (No-PTSD Group) with a group of military personnel with PTSD (PTSD Group).Baseline (Day 1)Our primary outcome measure involves a comparison of the proportions of individuals exhibiting a secure attachment style versus an insecure attachment style (including the subtypes anxious-avoidant, anxious-ambivalent, and disorganized) between the two groups, as assessed during the single study visit.

Countries

France

Contacts

CONTACTAnaïs Duffaud, PhD
anais.duffaud@intradef.gouv.fr0033 1 78 65 13 15
STUDY_DIRECTORAnaïs Duffaud, PhD

Institut de Recherche Biomédicale des Armées

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026